Trial TCTR20210731003
Publication Tawinprai K, Expert Rev Vaccines, 2022
Primary outcome on the report: Ratio of the geometric mean concentration (GMR) of the total anti-RBD antibody concentration post-vaccination compared with that pre-vaccination in each vaccine group.

Note: The risk of bias by domain corresponds to the highest risk of bias among outcomes by domain.
The overall risk of bias corresponds to the overall highest risk of bias assessed among outcomes.